Please login to the form below

Not currently logged in

Haemophilia Society launches UK awareness drive

Charity tackles poor understanding of bleeding disorder
Talking Red

The Haemophilia Society is making a bid to tackle poor understanding of bleeding disorders and raise awareness of the tens of thousands of women who may suffering from a bleeding disorder without realising it.

The UK charity is encouraging everyone to get 'Talking Red' during its first awareness week, launched on June 14 and supported by Grifols and CSL Behring, manufacturers of bleeding disorder medicines.  

The most common bleeding disorder in women is von Willebrand's, the charity said. Symptoms include frequent and heavy periods, bruising easily, frequent or heavy nosebleeds, bleeding heavily after surgery, prolonged bleeding after a dental procedure or abnormal bleeding after childbirth.

“There are tens of thousands of women in the UK currently living with a bleeding disorder without knowing. For many, this is because they think their symptoms are normal so they don't seek help,” said Liz Carroll, chief executive of the Haemophilia Society. 

“Our message is don't be embarrassed to talk about bleeding. The more we talk, the more informed women will be, and that can only help the thousands that are currently suffering in silence.”

Talking Red campaign events, including Paint it RED, and Red Knickers Night, will be staged across the UK to encourage people to be bold about bleeding. Participants can download posters and other materials from the campaign website

The pharma companies supporting the campaign are well-established providers of blood disorder treatments. 

Grifols develops plasma medicines, diagnostics systems, and hospital pharmacy products, while CSL Behring manufactures and markets a range of plasma-derived and recombinant therapies.

18th June 2014

From: Marketing, Healthcare



COVID-19 Updates and Daily News

Featured jobs


Add my company

Langland, a Publicis Health company, is the only health communications agency that thinks further across Clinical Trial Experience, Medical Strategy...

Latest intelligence

The disparity of patient experiences with Crohn’s Disease in Europe and Japan...
Patient diversity in clinical trials
The pursuit of patient diversity in clinical trials
When all-inclusive isn’t an option, it’s an obligation...
Overcoming the digital patient recruitment challenges of connecting with patients
How many irrelevant experiences, ads, emails, direct messages have you rejected this week?...